232 related articles for article (PubMed ID: 16153217)
21. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
Incrocci L; Slagter C; Slob AK; Hop WC
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):439-44. PubMed ID: 16965992
[TBL] [Abstract][Full Text] [Related]
22. Tadalafil for treatment of erectile dysfunction in men on antidepressants.
Segraves RT; Lee J; Stevenson R; Walker DJ; Wang WC; Dickson RA
J Clin Psychopharmacol; 2007 Feb; 27(1):62-6. PubMed ID: 17224715
[TBL] [Abstract][Full Text] [Related]
23. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
Blonde L
Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
Ali ST
Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
[TBL] [Abstract][Full Text] [Related]
25. Timing of dose relative to sexual intercourse attempt in previous sildenafil citrate users treated with tadalafil.
Glina S; Sotomayor M; Gatchalian E; Yaman O; Dyachkova Y; Markey C; Kopernicky V
J Sex Med; 2006 Mar; 3(2):309-19. PubMed ID: 16490025
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
Kloner RA; Jackson G; Hutter AM; Mittleman MA; Chan M; Warner MR; Costigan TM; Vail GM
Am J Cardiol; 2006 Jun; 97(12):1778-84. PubMed ID: 16765134
[TBL] [Abstract][Full Text] [Related]
27. An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries.
Mirone V; Costa P; Damber JE; Holmes S; Moncada I; Van Ahlen H; Wespes E; Cordell WH; Chan M; Lembo D; Varanese L
Eur Urol; 2005 Jun; 47(6):846-54; discussion 854. PubMed ID: 15925082
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction.
Saylan M; Khalaf I; Kadioglu A; Shoair KZ; Beheiry A; Wang WC; Kopernicky V; Esen A
Int J Clin Pract; 2006 Jul; 60(7):812-9. PubMed ID: 16846400
[TBL] [Abstract][Full Text] [Related]
29. Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: a multicentre, randomised, double-blind, placebo-controlled trial.
Heiman JR; Talley DR; Bailen JL; Oskin TA; Rosenberg SJ; Pace CR; Creanga DL; Bavendam T
BJOG; 2007 Apr; 114(4):437-47. PubMed ID: 17284249
[TBL] [Abstract][Full Text] [Related]
30. Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study.
Safarinejad MR
J Diabetes Complications; 2004; 18(4):205-10. PubMed ID: 15207837
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study.
Yip WC; Chiang HS; Mendoza JB; Tan HM; Li MK; Wang WC; Kopernicky V
Asian J Androl; 2006 Nov; 8(6):685-92. PubMed ID: 16855765
[TBL] [Abstract][Full Text] [Related]
32. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction.
Montorsi F; Verheyden B; Meuleman E; Jünemann KP; Moncada I; Valiquette L; Casabé A; Pacheco C; Denne J; Knight J; Segal S; Watkins VS
Eur Urol; 2004 Mar; 45(3):339-44; discussion 344-5. PubMed ID: 15036680
[TBL] [Abstract][Full Text] [Related]
33. Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US.
Rajfer J; Aliotta PJ; Steidle CP; Fitch WP; Zhao Y; Yu A
Int J Impot Res; 2007; 19(1):95-103. PubMed ID: 16871272
[TBL] [Abstract][Full Text] [Related]
34. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial.
Montorsi F; Nathan HP; McCullough A; Brock GB; Broderick G; Ahuja S; Whitaker S; Hoover A; Novack D; Murphy A; Varanese L
J Urol; 2004 Sep; 172(3):1036-41. PubMed ID: 15311032
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of sexual activity in patients treated with tadalafil: a randomized prospective placebo-controlled trial.
De Rose AF; Gallo F; Carmignani G
Int J Impot Res; 2005; 17(1):76-9. PubMed ID: 15510191
[TBL] [Abstract][Full Text] [Related]
36. Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis.
Valiquette L; Montorsi F; Hellstrom WJ; Giuliano F; Homering M; Taylor T; Eardley I;
Can J Urol; 2005 Jun; 12(3):2687-98; discussion 2699. PubMed ID: 16011816
[TBL] [Abstract][Full Text] [Related]
37. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
[TBL] [Abstract][Full Text] [Related]
38. Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction.
Buvat J; Hatzichristou D; Maggi M; Farmer I; Martínez-Jabaloyas JM; Miller PJ; Schnetzler G
BJU Int; 2008 Dec; 102(11):1645-50. PubMed ID: 18710446
[TBL] [Abstract][Full Text] [Related]
39. An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study.
Hellstrom WJ; Gittelman M; Jarow J; Steidle C; McMurray J; Talley D; Watts S; Mitchell CL; McGill JM
Eur Urol; 2008 May; 53(5):1058-65. PubMed ID: 17945409
[TBL] [Abstract][Full Text] [Related]
40. Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian 'Treatment of Erectile Dysfunction' observational study.
Lee J; Pommerville P; Brock G; Gagnon R; Mehta P; Krisdaphongs M; Chan M; Chan J; Dickson R
BJU Int; 2006 Sep; 98(3):623-9. PubMed ID: 16925764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
